Table 4.

Patients' assessments of secondary symptom scores at days 3, 6, 9, and 12 following treatment start of study 2.

Symptoms	d3	d6	d9	d12	P value (d3 versus d12)
Nose bleeding	0.70 ± 1.60	0.73 ± 1.72	0.50 ± 1.01	0.17 ± 0.59	0.0019
Pharyngitis	1.07 ± 2.26	0.67 ± 1.63	0.57 ± 1.19	0.60 ± 1.00	0.719
Exudate viscosity	2.67 ± 2.38	2.50 ± 2.64	2.10 ± 2.23	1.67 ± 2.19	0.027
Rhinorrhea	2.57 ± 1.99	2.00 ± 1.72	1.90 ± 1.83	1.57 ± 1.45	0.025
Cacosmia	0.90 ± 2.26	0.70 ± 1.82	0.33 ± 0.99	0.30 ± 0.99	0.005